Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers
In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished
NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors
Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says
National Policy: IOM Seeks Nominations for Cancer Policy Board
Grants Funding: R01 Payline To tighten To 22nd Percentile This Year, NCI Says.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help
